革命性的儿科神经母细胞瘤治疗:揭开精确干预的新分子标

Min Zheng1, Ankush Kumar2, Vishakha Sharma2

  • 1Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

概括

神经母细胞瘤 (NB),一个常见的儿童癌症,提出了各种挑战. 了解像ISL1和ROR1这样的遗传因素是开发向治疗和改善儿科癌症患者的生存率的关键.